Asset Purchase

12 Months Ended

Dec. 31, 2009

Asset Purchase [Abstract]

Asset Purchase [Text Block]

Asset Purchase

In 2009, the Company purchased the commercial rights and physical assets of Hospira’s critical care product line for $29.4 million in cash. 

With the completion of the transaction, the Company is responsible for sales, marketing, customer contracting and distribution for the critical care line.  In connection with the transaction, certain of the Company’s obligations to fund certain critical care research and to provide sales specialist support under the MCDA were released.